12-16 weeks for CE mark approval, page-37

Its on a downward trend because CE is taking forever. People are getting bored and why would you blame them when there are other things going on in the market.

This is not the first time we have been here. Same thing happened years ago when they originally went for CE. The share price went to 27 cents after the talks with BSI began and management were saying CE was immanent. Management gave a very specific time frame back then and when we passed that point and CE didnt land, the share price went into a descending triangle and gradually fell to pre CE hype.

They got knocked back and were asked to provide more data (back then only a handful of patients were implanted with Oncosil) and the share price promptly fell off a cliff.

Fast forward a few years and their position is much stronger...

- Two 2 trials on underway.

- Manufacturing and transportation processes for Oncosil bedded down.

- The bored has acquired some exceptional talent and leadership that have been around this industry for years and taken companies like these to v high peaks.

- IQVIA engaged to help with market access and sales strategy.

- Cash raised to see them through the immediate term and hopefully overlapping the period where CE is granted and sales can commence.

All we can hope for now is the data coming from clinical trials to continue the current trend (which seems to be very encouraging), and BSI to pull their finger out and grant CE.

If I had more cash, I'd be buying at these levels as CE far more likely this time. BSI said no back then and asked management to provide 40 patients that have been implanted for at least 16 weeks.. This has now been done, and the data / safety looks pretty damn good. On with the show fellas... Carry on.